Pınar Sırmatel Bücük
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pınar Sırmatel Bücük has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Asli Kilavuz
Department of İnternal Medicine, Faculty of Medicine, Ege University, Izmir 35100, Türkiye
3 shared publications - Cenab Batu Bora
College of Computing, Georgia Institute of Technology, Atlanta, GA 30332, USA
1 shared publication - Elif Ertuna
Department of Clinical Pharmacy, Faculty of Pharmacy, Ege University, Izmir 35040, Turkey
1 shared publication - Fatma Özge Kayhan Koçak
Division of Geriatrics, Department of Internal Medicine, Izmir Tepecik Education and Research Hospital Health Science University Izmir Turkiye
1 shared publication - Feryal Akşan1 shared publication
Irem Guray
(1, N=150) = 4.71, P=0.030 and 4.23, P=0.040, respectively)
1 shared publication
Latest Publications
- 10 March 2026
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 26 (3) , e70444
Turkish Adaptation, Validity and Reliability of the Pictorial Fit–Frail Scale
Aim: This study aimed to translate, culturally adapt, and evaluate the psychometric properties, including feasibility, reliability, and validity, of the Pictorial Fit–Frail Scale (PFFS) in Turkish older adults (PFFS‐TR). Methods: A multicenter methodological study was conducted with 202 older adults recruited from geriatrics outpatient clinics. The PFFS was translated and adapted using a six‐step protocol. Psychometric analyses included Confirmatory Factor Analysis (CFA) for construct validity, Kendall's tau‐b correlation with the Clinical Frailty Scale (CFS) for convergent validity, and Intraclass Correlation Coefficients (ICC) for test–retest and inter‐rater reliability. Results: Mean age was 72.99 ± 6.36 years; 67.8% were female. The PFFS‐TR demonstrated good internal consistency ( α = 0.881) and excellent reliability, with ICCs of 0.97 for test–retest and 0.98 for inter‐rater agreement. Convergent validity with the CFS was strong, showing a significant positive correlation (Kendall's tau‐ b = 0.629, p < 0.001). The scale also showed strong discriminative ability for CFS‐defined frailty (AUC = 0.877). The CFA results indicated that the unidimensional model provided partial support for the scale's structure. While the CFI and TLI values were within acceptable ranges (Comparative Fit Index = 0.91, Tucker–Lewis Index = 0.90), the RMSEA was 0.12, reflecting a significant indicator of discordance that suggests the model shows limited fit. Higher PFFS‐TR scores were significantly associated with older age, multimorbidity, hospitalization in past 6 months, using assistive devices, and falls. Conclusions: The PFFS‐TR is highly suitable for routine use in various clinical and community settings where screening is required, due to its low literacy requirements, strong visual support, and quick administration. It is a psychometrically practical, reliable, and valid screening‐first tool for identifying frailty in older adults in Türkiye, particularly prior to more advanced clinical assessment.
- 10 March 2026
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 26 (3) , e70444
Turkish Adaptation, Validity and Reliability of the Pictorial Fit–Frail Scale
Aim: This study aimed to translate, culturally adapt, and evaluate the psychometric properties, including feasibility, reliability, and validity, of the Pictorial Fit–Frail Scale (PFFS) in Turkish older adults (PFFS‐TR). Methods: A multicenter methodological study was conducted with 202 older adults recruited from geriatrics outpatient clinics. The PFFS was translated and adapted using a six‐step protocol. Psychometric analyses included Confirmatory Factor Analysis (CFA) for construct validity, Kendall's tau‐b correlation with the Clinical Frailty Scale (CFS) for convergent validity, and Intraclass Correlation Coefficients (ICC) for test–retest and inter‐rater reliability. Results: Mean age was 72.99 ± 6.36 years; 67.8% were female. The PFFS‐TR demonstrated good internal consistency ( α = 0.881) and excellent reliability, with ICCs of 0.97 for test–retest and 0.98 for inter‐rater agreement. Convergent validity with the CFS was strong, showing a significant positive correlation (Kendall's tau‐ b = 0.629, p < 0.001). The scale also showed strong discriminative ability for CFS‐defined frailty (AUC = 0.877). The CFA results indicated that the unidimensional model provided partial support for the scale's structure. While the CFI and TLI values were within acceptable ranges (Comparative Fit Index = 0.91, Tucker–Lewis Index = 0.90), the RMSEA was 0.12, reflecting a significant indicator of discordance that suggests the model shows limited fit. Higher PFFS‐TR scores were significantly associated with older age, multimorbidity, hospitalization in past 6 months, using assistive devices, and falls. Conclusions: The PFFS‐TR is highly suitable for routine use in various clinical and community settings where screening is required, due to its low literacy requirements, strong visual support, and quick administration. It is a psychometrically practical, reliable, and valid screening‐first tool for identifying frailty in older adults in Türkiye, particularly prior to more advanced clinical assessment.
- Open Access
- 1 February 2026
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 20, 1-11
Medication Regimen Complexity and Patient-Reported Adherence: A Cross-Sectional Study in Internal Medicine Outpatients
Purpose: Medication non-adherence and regimen complexity are significant barriers to achieving therapeutic goals. This study aimed to determine the impact of medication regimen complexity, and clinical characteristics of patients on medication adherence in internal medicine outpatients. Patients and Methods: This prospective cross-sectional study was conducted in the internal medicine and geriatric outpatient clinics of a tertiary university hospital. Adherence was assessed with Medication Adherence Report Scale (MARS-5), and regimen complexity was quantified using the Medication Regimen Complexity Index (MRCI) in 150 patients. Results: The mean age of the participants was 57.53± 1.26 years. Only 44% of the participants demonstrated perfect adherence to therapy. The MRCI scores of geriatric patients (median: 11 (3– 44) vs 19 (5– 65)) and those hospitalized within the last six months (median: 12.75 (3– 47) vs 20 (6– 65.5)) were significantly higher. Complexity scores related to dosing schedule and instructions for use were especially higher in patients with hypertension or diabetes. No statistically significant correlation was found between the total MRCI score and patient-reported adherence scores (P=0.32). However, geriatric patients and recently hospitalized patients were less likely to fully adhere to therapy (χ2 (1, N=150) = 4.71, P=0.030 and 4.23, P=0.040, respectively). Conclusion: Although a direct correlation between total regimen complexity and self-reported adherence was not observed, complexity poses a significant challenge for specific high-risk groups, including geriatric patients and those with recent hospitalizations. These findings may suggest that providing targeted medication counseling and medication regimen review, particularly in the early post-discharge period, might be crucial for optimizing adherence and clinical outcomes.
- 1 February 2026
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 20, 1-11
Open AccessMedication Regimen Complexity and Patient-Reported Adherence: A Cross-Sectional Study in Internal Medicine Outpatients
Purpose: Medication non-adherence and regimen complexity are significant barriers to achieving therapeutic goals. This study aimed to determine the impact of medication regimen complexity, and clinical characteristics of patients on medication adherence in internal medicine outpatients. Patients and Methods: This prospective cross-sectional study was conducted in the internal medicine and geriatric outpatient clinics of a tertiary university hospital. Adherence was assessed with Medication Adherence Report Scale (MARS-5), and regimen complexity was quantified using the Medication Regimen Complexity Index (MRCI) in 150 patients. Results: The mean age of the participants was 57.53± 1.26 years. Only 44% of the participants demonstrated perfect adherence to therapy. The MRCI scores of geriatric patients (median: 11 (3– 44) vs 19 (5– 65)) and those hospitalized within the last six months (median: 12.75 (3– 47) vs 20 (6– 65.5)) were significantly higher. Complexity scores related to dosing schedule and instructions for use were especially higher in patients with hypertension or diabetes. No statistically significant correlation was found between the total MRCI score and patient-reported adherence scores (P=0.32). However, geriatric patients and recently hospitalized patients were less likely to fully adhere to therapy (χ2 (1, N=150) = 4.71, P=0.030 and 4.23, P=0.040, respectively). Conclusion: Although a direct correlation between total regimen complexity and self-reported adherence was not observed, complexity poses a significant challenge for specific high-risk groups, including geriatric patients and those with recent hospitalizations. These findings may suggest that providing targeted medication counseling and medication regimen review, particularly in the early post-discharge period, might be crucial for optimizing adherence and clinical outcomes.
- Open Access
- 4 January 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Turkish-language Large Language Model-supported Voice Companion for Cognitive Monitoring via Social Artificial Intelligence in Older People Living Alone: A Single-Arm Pilot Study (Preprint)
BACKGROUND Older adults living alone are particularly vulnerable to reduced social interaction and loneliness, which are associated with adverse mental and physical health outcomes. At the same time, age-related cognitive decline becomes more prevalent, highlighting the growing need for scalable, technology-enabled interventions that can both mitigate social isolation and support routine cognitive monitoring in home settings. OBJECTIVE To develop iShe (Intelligent Social Health and Interaction), a Large Language Model (LLM)-supported mobile voice assistant designed to increase social interaction, reduce loneliness and depressive symptoms, and enable routine monitoring of the cognitive status of elderly adults living alone at home, and to evaluate its feasibility and acceptability. METHODS In this single-arm pilot feasibility study, ten community-dwelling adults aged 65 years and older living alone used the application for 30 days and were encouraged to complete one daily voice session. Loneliness and depressive symptoms were assessed at baseline and endline using the De Jong-Gierveld Loneliness Scale (DJGLS) and Geriatric Depression Scale-15 (GDS-15). Cognitive status was monitored in-app daily using the Short Portable Mental Status Questionnaire (SPMSQ), and the Standardized Mini-Mental State Examination (SMMSE) was administered face-to-face at baseline and endline. Paired changes were analyzed using Wilcoxon signed-rank tests and descriptive feasibility metrics (retention, adherence, session duration, support needs). RESULTS Retention was 100%. Participants completed all 30 sessions. Mean session duration was 18.6 ± 3.2 minutes. DJGLS decreased from 8.50 ± 5.28 to 5.70 ± 4.92 (p = 0.007; Cohen’s dz = 0.98; median change 2 [IQR 1–3.75]). GDS-15 decreased from 4.50 ± 4.22 to 2.30 ± 2.26 (p = 0.039; Cohen’s dz = 0.66; median change 1 [IQR 0–2]); the proportion scoring 6 or higher declined from 30% to 10%. SMMSE remained stable (29.3 ± 1.1 to 29.6 ± 0.7), and all SPMSQ results remained in the normal range (0–2 errors), consistent with SMMSE categories. CONCLUSIONS This pilot study provides strong feasibility and acceptability signals for daily use of an LLM- supported voice companion by older adults living alone, with exploratory within-group improvements in loneliness and depressive symptoms and stable, concordant cognitive screening outputs. Larger controlled studies are needed to establish efficacy and longer-term cognitive monitoring value.
- 4 January 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessTurkish-language Large Language Model-supported Voice Companion for Cognitive Monitoring via Social Artificial Intelligence in Older People Living Alone: A Single-Arm Pilot Study (Preprint)
BACKGROUND Older adults living alone are particularly vulnerable to reduced social interaction and loneliness, which are associated with adverse mental and physical health outcomes. At the same time, age-related cognitive decline becomes more prevalent, highlighting the growing need for scalable, technology-enabled interventions that can both mitigate social isolation and support routine cognitive monitoring in home settings. OBJECTIVE To develop iShe (Intelligent Social Health and Interaction), a Large Language Model (LLM)-supported mobile voice assistant designed to increase social interaction, reduce loneliness and depressive symptoms, and enable routine monitoring of the cognitive status of elderly adults living alone at home, and to evaluate its feasibility and acceptability. METHODS In this single-arm pilot feasibility study, ten community-dwelling adults aged 65 years and older living alone used the application for 30 days and were encouraged to complete one daily voice session. Loneliness and depressive symptoms were assessed at baseline and endline using the De Jong-Gierveld Loneliness Scale (DJGLS) and Geriatric Depression Scale-15 (GDS-15). Cognitive status was monitored in-app daily using the Short Portable Mental Status Questionnaire (SPMSQ), and the Standardized Mini-Mental State Examination (SMMSE) was administered face-to-face at baseline and endline. Paired changes were analyzed using Wilcoxon signed-rank tests and descriptive feasibility metrics (retention, adherence, session duration, support needs). RESULTS Retention was 100%. Participants completed all 30 sessions. Mean session duration was 18.6 ± 3.2 minutes. DJGLS decreased from 8.50 ± 5.28 to 5.70 ± 4.92 (p = 0.007; Cohen’s dz = 0.98; median change 2 [IQR 1–3.75]). GDS-15 decreased from 4.50 ± 4.22 to 2.30 ± 2.26 (p = 0.039; Cohen’s dz = 0.66; median change 1 [IQR 0–2]); the proportion scoring 6 or higher declined from 30% to 10%. SMMSE remained stable (29.3 ± 1.1 to 29.6 ± 0.7), and all SPMSQ results remained in the normal range (0–2 errors), consistent with SMMSE categories. CONCLUSIONS This pilot study provides strong feasibility and acceptability signals for daily use of an LLM- supported voice companion by older adults living alone, with exploratory within-group improvements in loneliness and depressive symptoms and stable, concordant cognitive screening outputs. Larger controlled studies are needed to establish efficacy and longer-term cognitive monitoring value.